Browsing publications by Professor John Isaacs

Newcastle AuthorsTitleYear
Professor John Isaacs
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort2014
Professor John Isaacs
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial2014
Dr Gary Reynolds
Dr Faye Cooles
Professor John Isaacs
Dr Catharien Hilkens
Emerging immunotherapies for rheumatoid arthritis2014
Dr Ken Baker
Professor John Isaacs
Prospects for therapeutic tolerance in humans2014
Professor John Isaacs
Can CD11c Expression Successfully Predict Response to Etanercept in Rheumatoid Arthritis Patients?2013
Professor John Isaacs
Differential Methylation Related to Response to Etanercept in Patients with Rheumatoid Arthritis2013
Professor John Isaacs
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis2013
Professor John Isaacs
Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis2013
Professor John Isaacs
Impact of IL-6R and IL-6ST Polymorphisms on Response to Anti-TNF Therapy in UK Patients – Results from the Braggss Cohort2013
Dr Amy Anderson
Christine Routledge
Philip Mawson
Professor John Isaacs
Dr Arthur Pratt
et al.
Interleukin-6 driven STAT3 phosphorylation in circulating lymphocytes is specific for CD4 T cells in early rheumatoid arthritis2013
1234567891011121314151617181920